Johnson & Johnson is a global healthcare conglomerate engaged in the research, development, and manufacture of pharmaceuticals, medical devices, and consumer health products. With a mission to improve health for humanity, J&J operates across three segments: Innovative Medicine, focusing on areas like oncology and immunology; MedTech, providing surgical and orthopedic solutions; and Consumer Health, offering products in baby care, skin health, and oral care. The company emphasizes innovation, sustainability, and global health equity, delivering solutions that impact millions worldwide.
Highlights include the debut of the Solutions in Motion™ initiative aimed at bringing together advanced surgical techniques, innovative implants, and data-driven enabling technologies.
The dual-use robotics and standalone navigation platform will become part of the VELYS™ Enabling Technologies Portfolio and integrate with existing J&J MedTech Spine products.
This is the first regulatory approval for the first-of-its-kind, fully-integrated Pulsed Field Ablation (PFA) system with a simple and reproducible workflow.
The INHANCE Shoulder System empowers surgeons to treat a broad range of cases with a streamlined, comprehensive implant offering that features common instrumentation and unique interoperative flexibility.
Janssen will also highlight its commitment to transform cancer care with more than 90 presentations showcasing robust, differentiated portfolio and pipeline in hematologic malignancies and solid tumours.